Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 10

Results: 24

Is Actinium Really Happening?

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1516, doi. 10.2967/jnumed.123.265907

By:

Zimmermann, Richard

Publication type:

Article

Potential of 188Re as an Alternative to 177Lu and Dosimetric Consequences.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1663, doi. 10.2967/jnumed.123.265782

By:

Pretze, Marc;
Kotzerke, Jörg;
Freudenberg, Robert;
Brogsitter, Claudia

Publication type:

Article

Preclinical Comparison of the 64Cu- and 68Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [68Ga]Ga-AMTG PET/CT.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1654, doi. 10.2967/jnumed.123.265771

By:

Koller, Lena;
Joksch, Markus;
Schwarzenböck, Sarah;
Kurth, Jens;
Heuschkel, Martin;
Holzleitner, Nadine;
Beck, Roswitha;
von Amsberg, Gunhild;
Wester, Hans-Jürgen;
Krause, Bernd Joachim;
Günther, Thomas

Publication type:

Article

Radiation Safety Considerations of Household Waste Disposal After Release of Patients Who Have Received [177Lu]Lu-PSMA-617.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1567, doi. 10.2967/jnumed.123.265750

By:

Graves, Stephen A.

Publication type:

Article

PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1526, doi. 10.2967/jnumed.123.265738

By:

van Lith, Sanne A. M.;
Pruis, Ilanah J.;
Tolboom, Nelleke;
Snijders, Tom J.;
Henssen, Dylan;
Laan, Mark ter;
Dorsthorst, Maarten te;
Leenders, William P. J.;
Gotthardt, Martin;
Nagarajah, James;
Robe, Pierre A.;
De Witt Hamer, Philip;
Hendrikse, Harry;
Oprea-Lager, Daniela E.;
Yaqub, Maqsood;
Boellaard, Ronald;
Wesseling, Pieter;
Balvers, Rutger K.;
Verburg, Frederik A.;
Harteveld, Anita A.

Publication type:

Article

Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1594, doi. 10.2967/jnumed.123.265725

By:

Gutsche, Robin;
Lowis, Carsten;
Ziemons, Karl;
Kocher, Martin;
Ceccon, Garry;
Brambilla, Cláudia Régio;
Shah, Nadim J.;
Langen, Karl-Josef;
Galldiks, Norbert;
Isensee, Fabian;
Lohmann, Philipp

Publication type:

Article

Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1532, doi. 10.2967/jnumed.123.265712

By:

Meiqi Wu;
Yanyu Wang;
Qiao Yang;
Xuezhu Wang;
Xu Yang;
Haiqun Xing;
Xinting Sang;
Xiang Li;
Haitao Zhao;
Li Huo

Publication type:

Article

Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1647, doi. 10.2967/jnumed.123.265686

By:

Mc Larney, Benedict Edward;
Mijin Kim;
Roberts, Sheryl;
Skubal, Magdalena;
Hsu, Hsiao-Ting;
Ogirala, Anuja;
Pratt, Edwin C.;
Kishore Pillarsetty, Naga Vara;
Heller, Daniel A.;
Lewis, Jason S.;
Grimm, Jan

Publication type:

Article

Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA--Refractory Metastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1574, doi. 10.2967/jnumed.123.265546

By:

Alan-Selcuk, Nalan;
Beydagi, Gamze;
Demirci, Emre;
Ocak, Meltem;
Celik, Serkan;
Oven, Bala B.;
Toklu, Turkay;
Karaaslan, Ipek;
Akcay, Kaan;
Sonmez, Omer;
Kabasakal, Levent

Publication type:

Article

[68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1660, doi. 10.2967/jnumed.123.265640

By:

Unterrainer, Lena M.;
Sisk Jr., Anthony E.;
Czernin, Johannes;
Shuch, Brian M.;
Calais, Jeremie;
Hotta, Masatoshi

Publication type:

Article

[177Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1570, doi. 10.2967/jnumed.123.265577

By:

Mercolli, Lorenzo;
Mingels, Clemens;
Manzini, Giulia;
Cumming, Paul;
Zeimpekis, Konstantinos;
Xue, Song;
Alberts, Ian;
Uehlinger, Dominik;
Rominger, Axel;
Kuangyu Shi;
Afshar-Oromieh, Ali

Publication type:

Article

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using 11C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1581, doi. 10.2967/jnumed.123.265569

By:

Bertoglio, Daniele;
Weiss, Alison R.;
Liguore, William;
Martin, Lauren Drew;
Hobbs, Theodore;
Templon, John;
Srinivasan, Sathya;
Dominguez, Celia;
Munoz-Sanjuan, Ignacio;
Khetarpal, Vinod;
Verhaeghe, Jeroen;
Staelens, Steven;
Link, Jeanne;
Liu, Longbin;
Bard, Jonathan A.;
McBride, Jodi L.

Publication type:

Article

The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node--Negative Prostate Cancer Patients.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1563, doi. 10.2967/jnumed.123.265556

By:

Duin, Jan J.;
de Barros, Hilda A.;
Donswijk, Maarten L.;
Schaake, Eva E.;
van der Sluis, Tim M.;
Wit, Esther M. K.;
van Leeuwen, Fijs W. B.;
van Leeuwen, Pim J.;
van der Poel, Henk G.

Publication type:

Article

68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1540, doi. 10.2967/jnumed.123.265664

By:

Kersting, David;
Sandach, Patrick;
Sraieb, Miriam;
Wiesweg, Marcel;
Metzenmacher, Martin;
Darwiche, Kaid;
Oezkan, Filiz;
Bölukbas, Servet;
Stuschke, Martin;
Umutlu, Lale;
Nader, Michael;
Hamacher, Rainer;
Fendler, Wolfgang P.;
Wienker, Johannes;
Eberhardt, Wilfried E. E.;
Schuler, Martin;
Herrmann, Ken;
Hautzel, Hubertus

Publication type:

Article

Albumin-Binding and Conventional PSMA Ligands in Combination with 161Tb: Biodistribution, Dosimetry, and Preclinical Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1625, doi. 10.2967/jnumed.123.265524

By:

Tschan, Viviane J.;
Busslinger, Sarah D.;
Bernhardt, Peter;
Grundler, Pascal V.;
Zeevaart, Jan Rijn;
Köster, Ulli;
van der Meulen, Nicholas P.;
Schibli, Roger;
Müller, Cristina

Publication type:

Article

Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1632, doi. 10.2967/jnumed.123.265523

By:

Mellhammar, Emma;
Dahlbom, Magnus;
Vilhelmsson-Timmermand, Oskar;
Strand, Sven-Erik

Publication type:

Article

Membrane and Nuclear Absorbed Doses from 177Lu and 161Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting--A Monte Carlo Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1619, doi. 10.2967/jnumed.123.265509

By:

Larouze, Alexandre;
Alcocer-Ávila, Mario;
Morgat, Clément;
Champion, Christophe;
Hindié, Elif

Publication type:

Article

68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1556, doi. 10.2967/jnumed.123.265489

By:

de Jong, Anouk C.;
Segbers, Marcel;
Sui Wai Ling;
Graven, Laura H.;
Mehra, Niven;
Hamberg, Paul;
Brabander, Tessa;
de Wit, Ronald;
van der Veldt, Astrid A. M.

Publication type:

Article

The Association Between [68Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1550, doi. 10.2967/jnumed.122.265368

By:

Mengxia Chen;
Yao Fu;
Shan Peng;
Shiming Zang;
Shuyue Ai;
Junlong Zhuang;
Feng Wang;
Xuefeng Qiu;
Hongqian Guo

Publication type:

Article

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1519, doi. 10.2967/jnumed.122.265247

By:

Albert, Nathalie L.;
Nelwan, Debie V.;
Fleischmann, Daniel F.;
Quach, Stefanie;
von Rohr, Katharina;
Kaiser, Lena;
Teske, Nico;
Unterrainer, Lena M.;
Bartos, Laura M.;
Ruf, Viktoria C.;
Brendel, Matthias;
Riemenschneider, Markus J.;
Wetzel, Christian;
Herms, Jochen;
Rupprecht, Rainer;
Thon, Niklas;
Tonn, Joerg-Christian;
Belka, Claus;
Bartenstein, Peter;
von Baumgarten, Louisa

Publication type:

Article

Stacking Ensemble Learning--Based [18F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1603, doi. 10.2967/jnumed.122.265244

By:

Shuilin Zhao;
Jing Wang;
Chentao Jin;
Xiang Zhang;
Chenxi Xue;
Rui Zhou;
Yan Zhong;
Yuwei Liu;
Xuexin He;
Youyou Zhou;
Caiyun Xu;
Lixia Zhang;
Wenbin Qian;
Hong Zhang;
Xiaohui Zhang;
Mei Tian

Publication type:

Article

Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1588, doi. 10.2967/jnumed.122.265225

By:

Cook, Brendon E.;
Nag, Sangram;
Arakawa, Ryosuke;
Yin-Shiang Lin, Edward;
Stratman, Nancy;
Guckian, Kevin;
Hering, Heike;
Lulla, Mukesh;
Choi, Jinkuk;
Salinas, Cristian;
Genung, Nathan E.;
Morén, Anton Forsberg;
Bolin, Martin;
Boscutti, Giulia;
Plisson, Christophe;
Martarello, Laurent;
Halldin, Christer;
Kaliszczak, Maciej A.

Publication type:

Article

Impact of Single-Time-Point Estimates of 177Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1610, doi. 10.2967/jnumed.122.264923

By:

Chicheportiche, Alexandre;
Sason, Moshe;
Zidan, Mahmoud;
Godefroy, Jeremy;
Krausz, Yodphat;
Gross, David J.;
Grozinsky-Glasberg, Simona;
Ben-Haim, Simona

Publication type:

Article

Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1638, doi. 10.2967/jnumed.122.265172

By:

Brown, Emma L.;
Shmuel, Shayla;
Mandleywala, Komal;
Panikar, Sandeep Surendra;
Berry, Na-Keysha;
Yi Rao;
Zidel, Abbey;
Lewis, Jason S.;
Pereira, Patrícia M. R.

Publication type:

Article

Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 10

Is Actinium Really Happening?

Potential of <sup>188</sup>Re as an Alternative to <sup>177</sup>Lu and Dosimetric Consequences.

Preclinical Comparison of the <sup>64</sup>Cu- and <sup>68</sup>Ga-Labeled GRPR-Targeted Compounds RM2 and AMTG, as Well as First-in-Humans [<sup>68</sup>Ga]Ga-AMTG PET/CT.

Radiation Safety Considerations of Household Waste Disposal After Release of Patients Who Have Received [<sup>177</sup>Lu]Lu-PSMA-617.

PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.

Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.

Comparison of Baseline <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib.

Ambient Light Resistant Shortwave Infrared Fluorescence Imaging for Preclinical Tumor Delineation via the pH Low-Insertion Peptide Conjugated to Indocyanine Green.

Clinical Experience with [<sup>225</sup>Ac]Ac-PSMA Treatment in Patients with [<sup>177</sup>Lu]Lu-PSMA--Refractory Metastatic Castration-Resistant Prostate Cancer.

[<sup>68</sup>Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis.

[<sup>177</sup>Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease.

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease.

The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node--Negative Prostate Cancer Patients.

<sup>68</sup>Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study.

Albumin-Binding and Conventional PSMA Ligands in Combination with <sup>161</sup>Tb: Biodistribution, Dosimetry, and Preclinical Therapy.

Tumor Control Probability and Small-Scale Monte Carlo Dosimetry: Effects of Heterogenous Intratumoral Activity Distribution in Radiopharmaceutical Therapy.

Membrane and Nuclear Absorbed Doses from <sup>177</sup>Lu and <sup>161</sup>Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting--A Monte Carlo Study.

<sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer.

The Association Between [<sup>68</sup>Ga]PSMA PET/CT Response and Biochemical Progression in Patients with High-Risk Prostate Cancer Receiving Neoadjuvant Therapy.

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.

Stacking Ensemble Learning--Based [<sup>18</sup>F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma.

Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain.

Impact of Single-Time-Point Estimates of <sup>177</sup>Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles.

Immuno-PET Detects Antibody-Drug Potency on Coadministration with Statins.